Pharma / Benefit Plan Settlements
There are often a number of active antitrust settlements and lawsuits that fall into the category of “pharmaceutical settlements.” Under these settlements, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or stabilized prices. The prices were allegedly manipulated as a result of anti-competitive practices undertaken by the drug manufacturers.
Eligible Pharma Product Date Range Settlement Fund Filing Deadline
Thalomid and Revlimid (cancer) Prior to August 2019 $55 million December 30, 2019
Provigil (sleep disorder / narcolepsy) June 2006 - Aug. 2019 $65 million January 15, 2020
The settlement covering Thalomid and Revlimid purchases includes organizations in the following locations:
- California, Florida, Kansas, Maine, Massachusetts, Michigan, Nebraska, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, or Tennessee
The settlement covering Provigil purchases includes organizations in the following locations:
- Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Mexico, New York, North Carolina, North Dakota, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wisconsin
Next Steps for MCAG Clients
Data is often required to complete your claim for settlements in this category. MCAG can quickly review the process with you so we can easily obtain necessary information from your Pharmacy Benefit Manager (i.e. CVS Caremark, Express Scripts, OptumRX) to pursue current and future pharmaceutical settlements. Should you wish to proceed, please contact an Account Manager at 800.355.0466 or send an email to firstname.lastname@example.org.